for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Astrazeneca Says Lynparza Approved In The EU For Prostate Cancer

Nov 5 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA PLC - LYNPARZA APPROVED IN THE EU FOR PROSTATE CANCER

* ASTRAZENECA- APPROVAL BY EUROPEAN COMMISSION WAS BASED ON A SUBGROUP ANALYSIS OF PROFOUND PHASE III TRIAL Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up